Literature DB >> 10906781

Histone acetylation is a checkpoint in FGF-stimulated mesoderm induction.

R H Xu1, Y Peng, J Fan, D Yan, S Yamagoe, G Princler, D Sredni, K Ozato, H F Kung.   

Abstract

We have previously demonstrated that the transcription factor, AP-1 (c-jun/c-fos heterodimer), mediates fibroblast growth factor (FGF) signaling during mesoderm induction in Xenopus embryo. In the present studies, we show that histone acetylation is involved in FGF-mediated signaling leading to mesoderm induction. Histone acetylation is a dynamic process regulated by the activities of two histone-modifying enzymes, the histone acetyltransferase(s) and histone deacetylase(s) (HDACs). We found that basal and FGF-regulated activator protein 1 (AP-1) activity in Xenopus embryo is markedly reduced by treatment of trichostatin A (TSA), a specific inhibitor of HDAC. However, activity of another transcription factor, NFkappaB, is enhanced by TSA treatment. AP-1-mediated mesoderm induction in the animal caps is dramatically suppressed by TSA at a dose-dependent manner. This suppression can be rescued by ectopic expression of HDAC3 at early stage. Finally, we found that histone acetylation in animal caps is inhibited by FGF whereas enhanced by TSA (as a control). Therefore, we propose that histone acetylation is a checkpoint for transduction of the FGF/AP-1 signals to induce mesoderm. Published 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906781     DOI: 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1024>3.0.CO;2-H

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  9 in total

1.  Histone Deacetylase Inhibitor M344 Inhibits Cell Proliferation and Induces Apoptosis in Human THP-1 Leukemia Cells.

Authors:  Xiaohua Li; Ben D Chen
Journal:  Am J Biomed Sci       Date:  2009-06-09

2.  Genetic and functional studies of phosphatidyl-inositol 4-kinase type IIIα.

Authors:  Zsofia Szentpetery; Gergely Szakacs; Naveen Bojjireddy; Andrew W Tai; Tamas Balla
Journal:  Biochim Biophys Acta       Date:  2011-05-13

3.  Histone acetylation regulates prostate ductal morphogenesis through a bone morphogenetic protein-dependent mechanism.

Authors:  Kimberly P Keil; Helene M Altmann; Lisa L Abler; Laura L Hernandez; Chad M Vezina
Journal:  Dev Dyn       Date:  2015-09-02       Impact factor: 3.780

4.  Transitory FGF treatment results in the long-lasting suppression of the proliferative response to repeated FGF stimulation.

Authors:  Ashleigh Poole; Nicholas Knowland; Emily Cooper; Rebecca Cole; Hongchuan Wang; Lucas Booth; Doreen Kacer; Francesca Tarantini; Robert Friesel; Igor Prudovsky
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

Review 5.  Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms.

Authors:  Kayla A Lewis; Trygve O Tollefsbol
Journal:  Front Genet       Date:  2016-05-09       Impact factor: 4.599

6.  Abrogation of Stem Loop Binding Protein (Slbp) function leads to a failure of cells to transition from proliferation to differentiation, retinal coloboma and midline axon guidance deficits.

Authors:  Katherine J Turner; Jacqueline Hoyle; Leonardo E Valdivia; Kara L Cerveny; Wendy Hart; Maryam Mangoli; Robert Geisler; Michele Rees; Corinne Houart; Richard J Poole; Stephen W Wilson; Gaia Gestri
Journal:  PLoS One       Date:  2019-01-29       Impact factor: 3.240

7.  The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses.

Authors:  José Manuel Afonso Moreira; Peter Scheipers; Poul Sørensen
Journal:  BMC Cancer       Date:  2003-11-09       Impact factor: 4.430

8.  Organ-specific requirements for Hdac1 in liver and pancreas formation.

Authors:  Emily S Noël; Antonio Casal-Sueiro; Elisabeth Busch-Nentwich; Heather Verkade; P Duc Si Dong; Derek L Stemple; Elke A Ober
Journal:  Dev Biol       Date:  2008-07-21       Impact factor: 3.582

9.  Histone deacetylase 1 is required for the development of the zebrafish inner ear.

Authors:  Yingzi He; Dongmei Tang; Wenyan Li; Renjie Chai; Huawei Li
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.